CURRICULUM VITAE ARNOLD I. MILLER, D.O., MBA, FACOI
|
|
- Myron Adams
- 8 years ago
- Views:
Transcription
1 CURRICULUM VITAE ARNOLD I. MILLER, D.O., MBA, FACOI FELLOWSHIPS: Hematology Martin Place Hospitals Madison Heights, MI - July 75 to June 76 Oncology Wayne State University Detroit, MI June 76 to June 77 BOARD CERTIFICATIONS: American Osteopathic Board of Internal Medicine 1. Internal Medicine 2. Medical Oncology 3. Hematology LICENSURE: Florida PUBLICATIONS: The Mallory-Weiss Syndrome: in the Michigan Osteopathic Journal, Vol. 34, November Ftotafur in Advanced Colorectal Carcinoma in Patients Previously Treated with Fluorinated Pyrimadines in the Cancer Treatment Reports, INTERESTS: Horseback riding with his lovely wife Candy Fly fishing
2 2 EDUCATION: HIGH SCHOOL: Weequahic High School Newark, NJ DEGREE: Diploma June 1964 UNIVERSITY: Boston University Boston, MA DEGREE: B.A., Psychology June 1968 MEDICAL SCHOOL: HONORS: Kansas City College of Osteopathic Medicine and Surgery Pi Sigma Alpha (Osteopathic Honor Society) Who s Who in American Colleges and Universities, 1972 DEGREES: D.O. June 1972 INTERNSHIP: RESIDENCY: POST GRADUATE STUDIES: Green Cross-General Hospital Cuyahoga Falls, OH June 1972 to June 1973 Internal Medicine Zeiger-Botsford Hospitals Farmington, MI July 1973 to June 1975 Physician MBA University of South Florida MEDICAL PRACTICE EXPERIENCE: Arnold I. Miller, D.O. Private Practice Portland, Oregon Osceola Cancer Center 1300 W. Oak Street Kissimmee, FL Present
3 3 PROFESSIONAL ACTIVITIES: 1. Director of Medical Education, Eastmoreland General Hospital Portland, OR, May 1982 July Member, Board of Directors, College of Osteopathic Medicine of the Pacific, Pomona, CA Served on various committees of the American Cancer Society. 4. Member, Teaching Staff, Emmanuel Hospital, Portland, OR. 5. Chairman, various committees at Eastmoreland General Hospital, Portland, OR. Including Long Range Planning, Bylaws, Administrative Search Committee, Locations, Intern Training, Tumor Board / Cancer Committee and Pharmacy & Therapeutics. 6. Vice-chairman, Department of Internal Medicine, Eastmoreland General Hospital, Portland, OR Guest lecturer at various community organizations. 8. Adjunct Clinical Faculty at Comp and Instructor of a yearly 18 hour course in Hematology, College of Osteopathic Medicine of the Pacific, Pomona, CA, Past Chairman of the Political Action Committee, Oregon Osteopathic Association. 10. Program Coordinator, Oregon/Washington Conference, Ashland, OR Liaison Physician, Oncology Unit, Eastmoreland General Hospital, Portland, OR. 12. Member, Board of Directors, American Cancer Society, West Osceola (Florida) Unit. 13. Medical Advisor, American Cancer Society, West Osceola (Florida) Unit. 14. Member, Board of Directors, Hospice of Osceola County, Florida. 15. Member, The Editorial Review Board for Journal of Managed Care Medicine. 16. Member, Physicians Advisory Board, Clinical Pharmacy Services. 17. Chairman, Physicians Advisory Board, Humana Care Plus. 18. Member, Physicians Advisory Board, Home Med Services. 19. Assistant Medical Director, Humana Care Plus, Osceola County.
4 4 20. Lecturer on various oncology topics including breast cancer, colon cancer, immunotherapy and pain control. Lectured at OCOI Spring Conference, February 28, 1986 and FOMA District XI, December 7, Speakers Bureau for DuPont Pharmaceutical and Purdue Frederick. 22. Chairman, Quality Assurance, Medical Records and Utilization Review Committees, Osceola Regional Hospital, Kissimmee, Fl. 23. Consultant, Sub-specialty of Hematology, American College of Osteopathic Internists. 24. Chairman, Department of Internal Medicine, Osceola Regional Hospital, Kissimmee, FL Named by Florida Governor, Bob Martinez to the C-CRAB, President, Medical Staff, Osceola Regional Hospital, Kissimmee, FL Associate Medical Director, Hospice of Central Florida, Member, Board of Trustees, Osceola Regional Hospital, Kissimmee, FL Physician Advisor, Osceola Regional Hospital, Kissimmee, FL, April Chairman, Board of Directors, Physicians Health Network (Columbia Park), August RESEARCH EXPERIENCE: Investigator, Southwestern Oncology Group (SWOG), through Eastmoreland General Hospital, Portland, OR (past). Investigator, Cancer and Leukemia Group B (CALGB) and National Surgical Adjuvant Bowel Project (NSABP), Walt Disney Memorial Cancer Institute, Florida Hospital, Orlando, FL in cooperation with Duke University, Orlando, FL Investigator, Radiation Therapy Oncology Group (RTOG), Osceola Regional Hospital, Kissimmee, FL., in cooperation with Johns Hopkins Hospital, Sub-Investigator, Faulding Pharmaceutical, Inc./ Harris Laboratories, Protocol CD-14556, A randomized, double-blind, Parallel Group Study Comparing the Efficacy and Safety of Kapanol to MS Contin in the Management of Patients with Moderate to Severe Cancer Pain, July 1993 to March 1994.
5 5 Sub-Investigator, Faulding Pharmaceuticals, Inc., /Harris Laboratories, Protocol CDD-14785, A long term Safety Evaluation of Kapanol and MS Contin in Patients with Moderate to Severe Cancer Pain, July 1993 to October Principal Investigator, Amgen, Inc., Research Protocol PR , Procrit (Epoeitin Alfa): Phase IV Clinical Evaluation in Anemic Patients Receiving Chemotherapy, September 1993 to May Sub-Investigator, ZENECA Pharmaceuticals Group, Protocol 1033IL/004, A Randomized, Multi-center, Efficacy and Safety Study to Evaluate Arimidex 1 and 10 mg double-blind, Compared to Open Label Megace in Post-menopausal Women with Advanced Breast Cancer, February Sub-Investigator, The Purdue Frederick Company, Protocol OC , double-blind, Randomized, Two-Period Crossover Efficacy Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of Immediate-Release Oxycodone and Controlled-Release Oxycodone in Cancer Patients with Pain, March 1994 to January Sub-Investigator, The Purdue Frederick Company, Protocol OC , Open-Label Clinical Use Study of Controlled-Release Oxycodone Tablets Administered Orally every 12 hours for the Management of Pain, March Sub-investigator, Pharmacia Inc., Protocol , Efficacy Trial of FCE (Exemestane) in the Treatment of Postmenopausal patients with Metastatic Breast Cancer Failing Tamoxifen, June Sub-Investigator, Pharmacia Inc., Protocol , Anti-tumor Efficacy Trial of FCE (Exemestane) as Third Line Hormonal Therapy in the Treatment of Postmenopausal Women with Metastatic Breast Cancer Refractory to Tamoxifen and Megace, June Sub-investigator, Pharmacia Inc., Protocol , Anti-tumor Efficacy Trial of FCE (Tallimustine) in the Treatment of Adult Patients with Renal Cell Carcinoma, September 1994 to August Sub-Investigator, Pharmacia Inc., Protocol 12005, Anti-tumor Efficacy Trial of FCE (Tallimustine) in the Treatment of Adult Patients with Adenocarcinoma of the Stomach or Gastro-Esophageal Junction, September 1994 to August Sub-Investigator, Pharmacia Inc., Protocol , Anti-tumor Efficacy Trial of FCE (Tallimustine) in the Treatment of Adult Patients with Carcinoma of the Pancreas, September 1994 to August Sub-Investigator, Roberts Pharmaceutical Corp., Protocol 13, B, An open Protocol for the use of Agrelin (Anagrelide) for Patients with Thrombocytemia, September 1994.
6 6 Sub-Investigator, The Purdue Frederick Company, Protocol OC , double-blind, Randomized, Q12H, Multiple-Dose, Parallel Group Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of Controlled-Release Oxycodone (Oxycontin) and MS Contin Tablets in Patients with Chronic Cancer-Related Pain, November 1994 to present. Sub-Investigator, Roberts Pharmaceutical, Protocol 38, B, An open Controlled Study of Deslorelin for the Treatment of Stage D2 Prostate Cancer, March 1995 to May Principal Investigator, Phone Poulenc Rorer Protocol 60180X-204A, A Randomized double blind Parallel Group Single Dose Comparative Study of RO60180 (0.5 mg and 7.5 mg) and Morphine Sulphate (20 mg), in patients with Cancer Pain, April 1995 to August Sub-Investigator, SoloPak Pharmaceuticals Inc. Protocol SP-MM-01, A Randomized, doubleblind, Multi-center Study of Low-Dose Gallium Nitrate for Treatment of Bone Involvement Due to Multiple Myeloma, August Sub-Investigator, Pharmacia Inc. Protocol 95-OEXE-022, Anti-tumor Efficacy of Exemestane in Postmenopausal Women with Metastatic Breast Cancer Failing Tamoxifen and Megace, September Sub-Investigator, Genetech, Inc., Protocol H2251n, Clinical Outcomes in Patients with HER2 Gene-Amplified Metastic Breast Cancer Treated with First-Line Herceptin in Combination with Taxane: phase IV, Prospective, Community-Based Study, July 2001 to present. Principal Investigator, Novartis Pharmaceuticals Corp., Protocol CZOL446EUS16, A Prospective, Multicenter, Open-Label Clinical Evaluation of the Effect of I.V. Zometa 4mg. On Pain, quality of Life and Time in Infusion Chair in Breast Cancer, Multiple Myeloma and Prostate Cancer Patients with Cancer-Related Bone Lesions, October 2001 to September 2002 Principal Investigator, Pharmacia, Inc., Protocol 378-ONC , Phase III Study of Epirubicin / Cyclophosphamide Followed by Taxane (Sequential Chemotherapy) versus Epirubicin / Taxane (Concurrent Chemotherapy) as Adjuvant Treatment for Operable, Node- Positive Breast Cancer, October 2001 to present. Principle Investigator, Amgen, Protocol NESP , An Open-Label, Randomized Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects with Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin alfa (NESP), October 2001 to present. Principle Investigator, Roche Pharmaceuticals, Protocol XEL-154, A Pilot Trial of Two Different Doses of Capecitabine (XELODA) in patients with Advanced and/or Metastatic Breast Cancer < November 2001 to present. Principal Investigator, Amgen, Protocol NESP , A Randomized, Open-Label, Comparatives Study to estimate the Effect of Darbepoetin alfa on Hospital Days, Economic Outcomes and Health-Related quality of Life in Subjects with Nonmeyloid Malignancies and Anemia of Cancer, November 2002 to present.
KELLI DEWITT WHITEHEAD, RN, MS, ARNP
CIRRICULUM VITAE KELLI DEWITT WHITEHEAD, RN, MS, ARNP Associated Urologist, PA 341 Wheatfield, Suite 180 Sunnyvale, TX 75182 972-270-8859 EDUCATION Master of Science, Family Nurse Practitioner University
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationS A N D R A C U E L L A R
S A N D R A C U E L L A R Professional Experience January 2006-Present September 2003-Present September 2003-Present Director, Oncology Specialty Residency University of Illinois at Chicago Medical Center
More informationAdrienne Boissy, MD, MA
Adrienne Boissy, MD, MA Cleveland Clinic Foundation Mellen Center for Multiple Sclerosis and Bioethics Neurological Institute Experience Officer 9500 Euclid Ave, U-10 Cleveland, Ohio 44195 Phone (216)
More informationCURRICULUM VITAE RUMPA AMORNMARN, M.D.
CURRICULUM VITAE RUMPA AMORNMARN, M.D. Office Address: Birth Place: Osceola Cancer Center 1300 West Oak Street Kissimmee, FL 34741 (407) 933-2775 * (866) 250-4679 Fax: (407) 933-8549 Burma UNDERGRADUATE
More informationGynäkologische Onkologie-Klinische Studien
Gynäkologische Onkologie-Klinische Studien Breast cancer A randomized, phase 2 trial of AEZS-108 in chemotherapy refractory triple negative (ER/PR/HER2-negative) LHRH-R positive metastatic breast cancer
More informationMOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
More informationInformation and Insight into Breast Cancer in China. White Paper. by Neesha Suvarna, PhD Consultant, Kantar Health November 2011
White Paper Catalysts driving successful decisions in life sciences. Information and Insight into Breast Cancer in China by Neesha Suvarna, PhD Consultant, Kantar Health November 2011 www.kantarhealth.com
More informationTreating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer
Breast Studies Adjuvant therapy after surgery Her 2 positive Breast Cancer B 52 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients with Hormone
More informationMegan Murphy-Menezes, Pharm.D., MSCR
University of Florida College of Pharmacy Telephone: 352-273-6533 2046 NE Waldo Road, Room 2241 Mobile: 910-200-4595 PO Box 113195 Fax: 352-273-6460 Gainesville, FL 32669 Email: mmenezes@cop.ufl.edu CURRENT
More informationInspira (Vineland/Woobury) Open Clinical Trials as of December 16, 2015
Inspira (Vineland/Woobury) Open Clinical Trials as of December 16, 2015 Advanced Refractory Solid Tumors or Lymphomas ECOG-ACRIN EAY131 (NCI CIRB) Targeted Therapy Directed by Genetic Testing in Treating
More informationCURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444
CURRICULUM VITAE PERSONAL INFORMATION Name: Address: Lindell A. Busciglio, M.D. 4729 North Habana Avenue 33614 (813) 251-8444 4 Columbia Drive, Suite 820 33606 Research Address: 4200 North Armenia Avenue
More informationBruce L. Hedgepeth, M.D
Curriculum Vitae Bruce L. Hedgepeth, M.D Personal: Home address: Phone: E- mail: 1995 N. 22 nd Avenue Ozark, Missouri 65721 417-860- 2534 (c) brucehedgepeth@gmail.com Education: Fellowship: Residency:
More informationEverolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer
LONDON CANCER NEWS DRUGS GROUP RAPID REVIEW Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer Everolimus plus exemestane for second-line
More informationCURRICULUM VITAE. 2004 to present 2001 to present 1998-2003
CURRICULUM VITAE Gina W. Duggar Clinical Coordinator of Adult Oncology Nell Hodgson Woodruff School of Nursing 1520 Clifton Road NE Atlanta, GA 30322 Tel: (770) 748-7140 Cell: (770) 547-0242 EDUCATION
More informationJune 2014 CURRICULUM VITAE. Peter E. Friedell, M. D. FACP. 2850 S. Wabash Suite 203. Chicago, Illinois
CURRICULUM VITAE June 2014 Peter E. Friedell, M. D. FACP. 2850 S. Wabash Suite 203 Chicago, Illinois 60616 312-808-0621 office 312-505-5106 cell 815-328-3833 fax pfriedell@gohms.com Personal: Date of Birth
More informationCARLTON DUANE RANDLEMAN, JR., M.D. CURRICULUM VITAE. Birmingham, Alabama 35243
CARLTON DUANE RANDLEMAN, JR., M.D. CURRICULUM VITAE Personal Information Birthplace Home Address Marital Status Spouse Atlanta, Georgia 2717 Old Trace 35243 Married Lynn Randleman Practice Information
More informationPATIENTS INITIATED AT FDA- APPROVED DOSING: RESULTS FROM PRACTICE PATTERNS IN A PROSPECTIVE OBSERVATIONAL STUDY
DRUG COST CONSIDERATIONS FOR ERYTHROPOIETIC STIMULATING AGENTS (ESAs) IN PATIENTS INITIATED AT FDA- APPROVED DOSING: RESULTS FROM PRACTICE PATTERNS IN A PROSPECTIVE OBSERVATIONAL STUDY Chris L. Pashos
More informationR E X C A N C E R C E N T E R. Annual Report 2012. Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care
R E X C A N C E R C E N T E R Annual Report 2012 Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care An American College of Surgeons Commission on Cancer Accredited Comprehensive
More informationBefore, Frank's immune cells could
Before, Frank's immune cells could barely recognize a prostate cancer cell. Now, they are focused on it. Stimulate an immune response against advanced prostate cancer Extend median survival beyond 2 years
More informationCURRICULUM VITAE STEVEN J. LANCASTER, M.D.
CERTIFICATION CURRICULUM VITAE STEVEN J. LANCASTER, M.D. JACKSONVILLE ORTHOPAEDIC INSTITUTE BEACHES DIVISION 410 JACKSONVILLE DRIVE JACKSONVILLE BEACH, FL 32250 904-241-1204 6/83 Diplomate National Board
More informationLisa A. Benson, BS CCRP, CRCP 9 Vexation Hill Drive Rocky Hill, Connecticut 06067 Email: labenso@connecticutchildrens.
Lisa A. Benson, BS CCRP, CRCP 9 Vexation Hill Drive Rocky Hill, Connecticut 06067 Email: labenso@connecticutchildrens.org 860-214-7375 Education: 2007-2013 California Coast University Santa Ana, CA Bachelors
More informationNCI Community Cancer Centers Program Program Overview Ascension Health St. Vincent Indianapolis Hospital
A. Name and location of hospital:, Indianapolis, IN B. Name of cancer center: St. Vincent Oncology Center C. Identify PI and key personnel with contact information for each pilot focus areas: a. Disparities
More informationOI PARP ΑΝΑΣΤΟΛΕΙΣ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ ΝΙΚΟΛΑΙΔΗ ΑΔΑΜΑΝΤΙΑ ΠΑΘΟΛΟΓΟΣ-ΟΓΚΟΛΟΓΟΣ Β ΟΓΚΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΝΟΣ. ΜΗΤΕΡΑ
OI PARP ΑΝΑΣΤΟΛΕΙΣ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ ΝΙΚΟΛΑΙΔΗ ΑΔΑΜΑΝΤΙΑ ΠΑΘΟΛΟΓΟΣ-ΟΓΚΟΛΟΓΟΣ Β ΟΓΚΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΝΟΣ. ΜΗΤΕΡΑ Study Overview Inhibition of poly(adenosine diphosphate [ADP]-ribose) polymerase
More informationHow To Know If You Have Cancer At Mercy Regional Medical Center
MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want
More informationCHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
More informationCURRICULUM VITAE. Medical Director, University Pain Medicine Center TELEPHONE NUMBER/FAX NUMBER: (732) 873-6868 / (732) 873-6869
CURRICULUM VITAE DATE: December 2014 NAME: PRESENT TITLE: Didier Demesmin, MD Medical Director, University Pain Medicine Center OFFICE ADDRESS: 33 Clyde Road, Suites 105-106, Somerset, NJ 08873 TELEPHONE
More informationGuidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products
Guidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationBreast Cancer Update 2014 Prevention, Risk, and Treatment of Early Stage Breast Cancer. Kevin R. Fox, MD University of Pennsylvania
Breast Cancer Update 2014 Prevention, Risk, and Treatment of Early Stage Breast Cancer Kevin R. Fox, MD University of Pennsylvania Prevention of Breast Cancer Accepted treatments Tamoxifen (premenopausal
More informationCellular, Molecular, and Biochemical Targets in Breast Cancer
Cellular, Molecular, and Biochemical Targets in Breast Cancer Kristy Kummerow Ingrid Meszoely December 12, 2012 VUMC Resident Bonus Conference One size fits all surgical treatment of breast cancer Wilhelm
More informationGuidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials
More informationCENTER FOR DRUG EVALUATION AND RESEARCH. 203551Orig1s000
CENTER FOR DRUG EVALUATION AND RESEARCH Approval Package for: APPLICATION NUMBER: Trade Name: Generic Name: Sponsor: 203551Orig1s000 Docetaxel Injection Concentrate, 20 mg/ml, 80 mg/4 ml, 140 mg/7 ml.
More informationCURRICULUM VITAE KIRK GEORGE VOELKER, M.D.
PERSONAL INFORMATION DATE OF BIRTH December 29, 1961 PLACE OF BIRTH OFFICE ADDRESS E-MAIL Buffalo, NY. 1537 State St. 34236 (941) 330-1696 Dr.Voelker@comcast.net ACADEMIC RECORD UNDERGRADUATE MEDICAL SCHOOL
More informationRodney C. Lester, PhD, CRNA 6901 Bertner, Suite 684 Houston, TX 77030 731-500-2176/713-500-2171 FAX Rodney.C.Lester@uth.tmc.edu
6901 Bertner, Suite 684 Houston, TX 77030 731-500-2176/713-500-2171 FAX Rodney.C.Lester@uth.tmc.edu EDUCATION PhD Texas A&M University 05/1988 College Station, TX MSN University of Tennessee Memphis, Tennessee
More informationCathy Payne, RN, MSN, ACNP-BC
Cathy Payne, RN, MSN, ACNP-BC PROFESSIONAL ADDRESS CURRICULUM VITAE Ironwood Cancer & Research Centers a division of Ironwood Physicians, PC 11209 N. Tatum Blvd #260 Phone: 602-494-6800 Fax: 602-494-6803
More informationCOMPENDIA TRANSPARENCY TRACKING FORM. Sunitinib malate. Metastatic breast cancer, HER2-negative
COMPENDIA TRANPARENCY TRACKING FORM DRUG: unitinib malate INDICATION: Metastatic breast cancer, HER2-negative COMPENDIA TRANPARENCY REQUIREMENT 1 Provide criteria used to evaluate/prioritize the request
More informationCurriculum Vitae. James W. Loewenherz, M.D., F.A.C.P
Personal Office Address: 9000 SW 87 th Court Suite 215 Miami, FL 33176 Mailing Address: PO Box 56-2121 Miami, FL 33256-2121 Telephone: 305-274-4800 Fax: 305-279-6462 Email: dr.nephron@gmail.com Alternate
More informationEmerging Drug List GEFITINIB
Generic (Trade Name): Manufacturer: Gefitinib (Iressa ) formerly referred to as ZD1839 AstraZeneca NO. 52 JANUARY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence:
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationClinical Trials Currently Open At Genesis Health System
A Multicenter, Randonmized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Cord Injury.
More informationNot All Clinical Trials Are Created Equal Understanding the Different Phases
Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact
More informationCurriculum Vitae. Richard Y. Lam 4676 Admiralty Way, Suite 101 Marina del Rey, CA 90292 T: 310 827 7707 E: richard@prostateoncology.
Curriculum Vitae Richard Y. Lam 4676 Admiralty Way, Suite 101 Marina del Rey, CA 90292 T: 310 827 7707 E: richard@prostateoncology.com DEA: BL5206190 CA License: A60442 NPI: 1811925258 Education Undergraduate
More informationCURRICULUM VITAE. Joseph Anthony Giaimo, D.O. FCCP, FACOI. 1011 Singer Drive West Palm Beach, FL 33404 561-845-9991 giaimoj@comcast.
CURRICULUM VITAE Joseph Anthony Giaimo, D.O. FCCP, FACOI 1011 Singer Drive West Palm Beach, FL 33404 561-845-9991 giaimoj@comcast.net PERSONAL DATA Date of Birth: March 16, 1961 Norristown, Pennsylvania
More informationTreatment & Research. Treatment & Research
Treatment & Research In March 1990, I became ill while on a trip to Thailand. I was examined and tested and given instructions to go to the emergency room when I arrived at home. In Great Falls, I learned
More informationTracy B. White, M.S., R.T. (R)(T)
Tracy B. White, M.S., R.T. (R)(T) EDUCATION August 2000 Arkansas State University Master of Science 1988-1989 Central Arkansas Radiation Therapy Institute Certificate of Radiation Therapy Technology Awards:
More informationBREAST CANCER WHAT HAPPENS AFTER SURGERY?
BREAST CANCER WHAT HAPPENS AFTER SURGERY? Contents: Planning further treatment Medical management of breast cancer Support and follow up Questions to ask your surgeon or oncologist Planning further treatment
More informationPATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. Radiation Oncology Sidney Kimmel Cancer Center at Johns Hopkins Last
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationRole of clinical trials in professional development
Role of clinical trials in professional development Peeter Padrik Tartu University Hospital University of Tartu Estonian Society for Medical Oncology How we do treatment decisions? Personal experience?
More informationJonathan R. Gottlieb, MD 7220 SW 127 Street Pinecrest, FL 33156 jonrgottlieb@gmail.com
Jonathan R. Gottlieb, MD 7220 SW 127 Street Pinecrest, FL 33156 jonrgottlieb@gmail.com CURRENT PRACTICE September 2009-present University of Miami School of Medicine Assistant Professor, Department of
More informationMeet Your Sparrow Cancer Center Team
Meet Your Sparrow Cancer Center Team Our integrated, multidisciplinary approach means every Patient is evaluated and cared for by a team managing all aspects of care from tests and treatments, to infusions,
More informationOPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose
OPIOID CONVERSIONS 1. Converting Short acting Long Acting (IR SR) when pain is well controlled *Use for : CHRONIC pain Pts on scheduled IR opioids pain that recurs before the next dose PP: Can use equianalgesic
More informationNational Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div.
Dated 21 st November 2014 NPPA Invites Comments of Pharmaceutical Industry & Trade, Consumer Organisations, Public Health Experts and other Stakeholders on the Recommendations of Tata Memorial Centre under
More informationMichigan Department of Licensing and Regulatory Affairs Pain and Symptom Management Speakers Bureau
Michigan Department of Licensing and Regulatory Affairs Pain and Symptom Management Speakers Bureau Are you looking for a speaker to present at your conference, ground rounds, or brown bag lunch? If you
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description
More informationCURRICULUM VITAE JENNIFER A. ROBERTS
UAMS Medical Center 4301 W. Markham St. Slot 571 Little Rock, AR 72205 Phone: (501) 686-6246 Fax: (501) 686-7927 Email: robertsjennifera@uams.edu CURRICULUM VITAE JENNIFER A. ROBERTS EDUCATION University
More informationMichael Friedman, MPT, MBA CURRICULUM VITAE
Michael Friedman, MPT, MBA CURRICULUM VITAE January 14, 2014 Michael Friedman DEMOGRAPHIC AND PERSONAL INFORMATION Current Appointments Director Rehabilitation Therapy Services, Physical Medicine and Rehabilitation,
More informationisbtc/sitc Exceptional Service Award Recipients
isbtc/sitc Exceptional Service Award Recipients Awarded October 3, 2010 for distinguished leadership, continued contribution, and consummate dedication which fostered the growth and success of isbtc. Michael
More informationCo-pay assistance organizations offering assistance
Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin
More informationDefinition of Investigational Medicinal Products (IMPs) Definition of Non Investigational Medicinal Products (NIMPs)
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Definition of Investigational Medicinal Products (IMPs) Definition of Non Investigational Medicinal Products
More informationKey Staff Members EXECUTIVE TEAM Nancy Price Mendenhall, MD Medical Director Stuart Klein, MHA Executive Director Zuofeng Li, DSc Physics Director
Key Staff Members EXECUTIVE TEAM Nancy Price Mendenhall, MD Medical Director A University of Florida College of Medicine faculty member since 1985, Dr. Mendenhall served as the chair of the Department
More informationRotating Internship, Royal Brisbane Hospital and Redcliffe Hospital, Queensland, Australia
Curriculum Vitae Name: E-Mail: Place of Birth: David Mee-Lee, M.D. (Australian equivalent is M.B., B.S.) M.S. dmeelee@changecompanies.net Brisbane, Queensland, Australia Education 1972 M.B., B.S., Bachelor
More informationMitzi M. Saunders, Ph.D., R.N. Associate Professor
Mitzi Saunders - Curriculum Vitae Mitzi M. Saunders, Ph.D., R.N. Associate Professor College of Health Professions University of Detroit Mercy P.O. Box 19900 313.993.1767 (office) 313.993.1271 (fax) saundemm@udmercy.edu
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More informationStrength of Study End Point(s): Progression-free survival
AHFS Final Determination of Medical Acceptance: Off-label Use of Bevacizumab in Combination with Paclitaxel for the First-line Treatment of Metastatic Breast Cancer Drug/Drug Combination: Bevacizumab and
More informationProstate Cancer Studies
Prostate Cancer Studies STUDIES CURRENTLY RECRUITING MDV3100-14 A multinational, Phase 3, Randomized, Double- Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastic
More informationBreast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
More informationCURRICULUM VITAE. Email: jasonjia88@yahoo.com
CURRICULUM VITAE Email: jasonjia88@yahoo.com AACSB Post-Doctoral Bridge Program (PDB), 08/2009 Hough Graduate School of Business, Warrington College of Business Administration University of Florida, Gainesville,
More informationCURRICULUM VITAE Richard M. Rankl MD, MS, FAAFP
CURRICULUM VITAE Richard M. Rankl MD, MS, FAAFP Assistant Program Director, Family Practice Residency Program Department of Medical Education, Genesys Regional Medical Center Associate Clinical Professor,
More informationCURRICULUM VITAE GREGORY JAMES FERREIRA M.D., FCCP
CURRICULUM VITAE GREGORY JAMES FERREIRA M.D., FCCP Business address: Hautamaki & Horiuchi Personal Physicians of Sarasota 1843 Floyd Street Sarasota, Fl Phone: 941.951.3920 Fax: 941.951.3922 Prior business
More informationBristol Hospital Cancer Care Center 2015 Annual Report
Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the
More informationIBRANCE is not approved for any indication in any market outside the U.S.
IBRANCE (palbociclib) Fact Sheet IBRANCE (palbociclib) is an oral inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. IBRANCE is indicated in combination with letrozole for the treatment of postmenopausal
More informationOPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 AGENDA
OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 Friday, June 26 AGENDA 10:00 am - 10:45 am Registration; Breakfast
More informationJanuary 2013 LONDON CANCER NEW DRUGS GROUP RAPID REVIEW. Summary. Contents
LONDON CANCER NEW DRUGS GROUP RAPID REVIEW Paclitaxel albumin (Abraxane ) as a substitute for docetaxel/paclitaxel for cancer Paclitaxel albumin (Abraxane ) as a substitute for docetaxel/ paclitaxel for
More informationGuidance for Industry
Guidance for Industry Cancer Drug and Biological Products Clinical Data in Marketing Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and
More informationOptimizing Adoption of Advanced Technology to Achieve High Value Cancer Care: The Case of Proton Therapy ECRI NCI Conference November 17, 2015
Optimizing Adoption of Advanced Technology to Achieve High Value Cancer Care: The Case of Proton Therapy ECRI NCI Conference November 17, 2015 Justin E. Bekelman, MD Associate Professor, Radiation Oncology
More informationTimothy J. York, DO, FACOP
Timothy J. York, DO, FACOP Office Address: Lincoln Memorial University DeBusk College of Osteopathic Medicine 6965 Cumberland Gap Parkway Harrogate, Tennessee 37752 Office Phone: (423) 869-7010 Office
More informationYour Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer
Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis
More informationINOEL RIVERA 1812 North Mills Avenue Orlando, Florida 32803 (407) 897-3499
INOEL RIVERA 1812 North Mills Avenue Orlando, Florida 32803 (407) 897-3499 PERSONAL DATA Date of Birth: May 21, 1965 Place of Birth: Mayaguez, Puerto Rico Citizenship: U.S. Marital Status: Married to Carmen
More informationPHYSICIANS / SURGEONS
PHYSICIANS / SURGEONS American Academy of Audiology American Academy of Neurology American Academy of Physical Medicine & Rehabilitation American Academy of Ophthalmology Academy of Correctional Health
More informationIMMUNOMEDICS, INC. February 2016. Advanced Antibody-Based Therapeutics. Oncology Autoimmune Diseases
IMMUNOMEDICS, INC. Advanced Antibody-Based Therapeutics Oncology Autoimmune Diseases February 2016 Forward-Looking Statements This presentation, in addition to historical information, contains certain
More informationTITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software.
SAMPLE CLINICAL RESEARCH APPLICATION ABSTRACT: TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software. Hypothesis:
More informationMechanism Of Action of Palbociclib & PFS Benefit
A Phase II Randomized Controlled Trial of Palbociclib & Tamoxifen/Fulvestrant in Postmenopausal Women and Men With Hormone-Receptor Positive, HER2- Negative Metastatic Breast Cancer (MBC) Protocol Chair:
More informationGeorge J. Hruza, MD, MBA Laser and Dermatologic Surgery Center (St. Louis University) 1001 Chesterfield Parkway East Suite 101 Chesterfield, MO 63017
George J. Hruza, MD, MBA Laser and Dermatologic Surgery Center (St. Louis University) 1001 Chesterfield Parkway East Suite 101 Chesterfield, MO 63017 If you are interested in having Dr. George J. Hruza
More informationLevel 1. Nutrition & Lifestyle Oncology Certificate
Level 1 Nutrition & Lifestyle Oncology Certificate ONE MODULE 1 A Cancer Diagnosis Learn what cancer is; how/why it develops; diagnostic tests; inflammatory/ hormonal connections; 5 most important steps
More informationBackground. t 1/2 of 3.7 4.7 days allows once-daily dosing (1.5 mg) with consistent serum concentration 2,3 No interaction with CYP3A4 inhibitors 4
Abstract No. 4501 Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a Phase III randomized, open-label, multicenter trial R. Motzer, D.
More informationCancer Care Delivered Locally by Physicians You Know and Trust
West Florida Physician Office Building Johnson Ave. University Pkwy. Olive Road N. Davis Hwy. For more information on West Florida Cancer Center: 850-494-5404 2130 East Johnson Avenue Pensacola, Florida
More informationChemotherapy or Not? Anthracycline or Not? Taxane or Not? Does Density Matter? Chemotherapy in Luminal Breast Cancer: Choice of Regimen.
Chemotherapy in Luminal Breast Cancer: Choice of Regimen Andrew D. Seidman, MD Attending Physician Breast Cancer Medicine Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Cornell
More informationBreast Cancer Drug Discoveries: What the Future Holds
Brochure More information from http://www.researchandmarkets.com/reports/679630/ Breast Cancer Drug Discoveries: What the Future Holds Description: In 2010, almost 50% of breast cancer sales were due to
More informationCharles William Sponsel, D.O, MA Sci Ed, FAAFP 701 West 5 th Street, Odessa, Texas 79763 432-335-5311 Charles.Sponsel@ttuhsc.edu
Charles William Sponsel, D.O, MA Sci Ed, FAAFP 701 West 5 th Street, Odessa, Texas 79763 432-335-5311 Charles.Sponsel@ttuhsc.edu Post-Graduate Training Resident, July 1990 1992, Department of Family Medicine,
More informationCURRICULUM VITAE. 9/61 to 6/62 Pre-Med Kansas State Teachers College Emporia, KS
Date: October 21, 2010 CURRICULUM VITAE PERSONAL DATA First Name David Last Name Deer Current Academic Rank Clinical Assistant Professor Department(s) Radiation Oncology Office Address 3901 Rainbow Blvd.,
More informationThe Impact of Taxotere on Adjuvant Breast Cancer
The Impact of Taxotere on Adjuvant Breast Cancer a report by Pierre Fumoleau and Henri Roché Centre Georges François Leclerc, Dijon, and Institut Claudius Regaud, Toulouse, France DOI: 10.17925/EOH.2005.0.0.1l
More informationDavid K. Chatkoff, Ph.D. Curriculum Vitae - 2010
Current Position: Associate Professor of Psychology (2010- Present) University of Michigan- Dearborn 1 EDUCATION: Clinical Health Psychology Postdoctoral Fellowship, (2004) Clinical Health Psychology Service
More informationRole of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases
Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases R. Shraddha, P.N. Pandit Radium Institute, Patna Medical College and Hospital, Patna, India Abstract NHL is a highly
More informationBreast Cancer Treatment Guidelines
Breast Cancer Treatment Guidelines DCIS Stage 0 TisN0M0 Tamoxifen for 5 years for patients with ER positive tumors treated with: -Breast conservative therapy (lumpectomy) and radiation therapy -Excision
More informationAeterna Zentaris. 11 th Annual Needham Healthcare Conference April 3, 2012. Committed to cure
11 th Annual Needham Healthcare Conference April 3, 2012 Forward-Looking Statements This presentation contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities
More informationCurriculum Vitae. NORMAN E. VINN, D.O., M.B.A. 260 Calle Campesino Phone: 949-366-1053 San Clemente, CA 92672 Fax: 949-498-0930
Curriculum Vitae NORMAN E. VINN, D.O., M.B.A. 260 Calle Campesino Phone: 949-366-1053 San Clemente, CA 92672 Fax: 949-498-0930 PROFESSIONAL HISTORY HOUSECALL DOCTORS MEDICAL GROUP, INC. 2002-Present Founder
More informationMetastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011
Metastatic Breast Cancer 201 Carolyn B. Hendricks, MD October 29, 2011 Overview Is rebiopsy necessary at the time of recurrence or progression of disease? How dose a very aggressive treatment upfront compare
More informationLow dose capecitabine is effective and relatively nontoxic in breast cancer treatment.
1 Low dose capecitabine is effective and relatively nontoxic in breast cancer treatment. John T. Carpenter, M.D. University of Alabama at Birmingham NP 2508 1720 Second Avenue South Birmingham, AL 35294-3300
More information